Predictability of monthly and yearly rhythms of breast cancer features

Breast Cancer Research and Treatment

Volumn 67, Issue 1, 2001, Pages 41-49

  Paradiso, A ^a   Serio, G ^b   Fanelli, M ^b   Mangia, A ^a   Cellamare, G ^a   Schittulli, F ^a  

^a NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Biological characteristics; Menstrual variations; Predictability; Seasonal variations

Indexed keywords

STEROID RECEPTOR;

ARTICLE; BREAST CANCER; CANCER PATIENT; CLINICAL FEATURE; FEMALE; HUMAN; HUMAN TISSUE; MENSTRUAL CYCLE; PERIODICITY; PRIORITY JOURNAL; SEASONAL VARIATION; TUMOR VOLUME;

BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; MENOPAUSE; MENSTRUAL CYCLE; PERIODICITY; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SEASONS; THYMIDINE;

EID: 0034894833     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010658804640     Document Type: Article

References (49)

1. A menstrual timing of breast cancer surgery
2. Plasma concentration of LH, FSH, prolactin, progesterone and estrodiol-17b throughout the 4-day estrous cycle of the rat
3. Evidence for an ontogenetic basis for circadian coordination of cancer cell proliferation
4. Expression of PS2, C-ERB-2 and chatepsin D during the mestrual cycle in human breast tumors
5. The effect of age and menstrual cycle upon proliferative activity of the normal human breast
6. Menstrual cycle-dependent variations of breast cyst fluid proteins and sex steroid receptors in the normal human breast
7. The correlation of histologic changes in the human breast with the mestrual cycle
8. Menstruation pattern and month of birth
9. Disruption of the circadian patterns of serum cortisol in breast and ovarian cancer patients: Relationships with tumour marker antigens
10. Changes in estrogen and progesterone receptor content of primary breast carcinoma during the menstrual cycle
11. Timing of surgery during the menstrual cycle for breast cancer: Possible role of growth factors
12. Effects of menstrual phase on surgical treatment of breast cancer
13. Variation in histology and oestrogen receptor content in breast carcinoma related to tumour size and time of presentation
14. Birth seasonality of breast cancer patients and its variation according to menopausal status and histologic type in Japan
15. Micrometastases to the axilla in breast cancer: Their size and season of presentation
16. Seasonal presentation of cases with positive efferent vascular status in the axillary nodes
17. Seasonal variation in breast cancer detection: Correlation with tumour progesterone receptor status
18. Seasonal change in the concentration of progesterone receptor in breast cancer
19. Circannual rhythms in steroid receptor concentration in gynecologic and breast cancers
20. Absence of seasonal variation of estrogen receptor levels in human breast cancer
21. Seasonal variation in the secretion of mammotrophic hormones in normal women and women with previous breast cancer
22. Seasonal changes in serum melatonin in women with previous breast cancer
23. Season of initial discovery of tumour as an independent variable predicting survival in breast cancer
24. Does the month of diagnosis affect survival of cancer patients?
25. Menstrual phase and timing of breast cancer surgery: Statistical aspects
26. Reproducible and predictable yearly pattern in the incidence of uterine cervical cancer
27. Histologic grading of breast cancer
28. Revision of the standards for the assessment of hormone receptor in human breast cancer
29. Tumor-proliferative activity, progesterone receptor status, estrogen receptor level and clinical outcome of estrogen receptor-positive advanced breast cancer
30. Heterogeneity of intratumour proliferative activity in primary breast cancer: Biological and clinical aspects
31. Feasibility and reproducibility of the [3H]-thymidine labelling index in breast cancer, the SICCAB group for quality control of cell kinetic determination
32. Effect of menstrual phase on surgical treatment of breast cancer
33. Variations in prognostic factors in primary breast cancer throughout the menstrual cycle
34. Proliferation of the breast epithelium in relation to menstrual cycle phase, hormonal use, and reproductive factors
35. Estradiol and progesterone receptor levels in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels
36. Variations in estrogen and progesterone receptor content in premenopausal breast cancer patients throughout the menstrual cycle
37. Influence of the menstrual cycle on the concentrations of estrogen and progesterone receptors in primary breast cancer biopsies
38. Influence of menstrual cycle, parity and oral contraceptive use on steroid hormone receptors in normal breast
39. Changing estrogen and progesteron receptor patterns in breast carcinoma during the menstrual cycle and menopause
40. Timing of surgery influences survival in receptor-negative as well as receptor-positive breast cancer
41. Levels of estrogen and progesterone receptor proteins in patients with breast cancer during various phases of the menses
42. Timing of breast cancer surgery within the menstrual cycle: Tumor proliferation activity, receptor status and short-term clinical outcome
43. Changes in estrogen and progesterone receptor content of primary breast carcinoma during the menstrual cycle
44. Psychosocial menstrual disorders: Stress, exercise and diet's effect on the menstrual cycle
45. Inverse seasonal relationship between melatonin and ovarian activity in humans in a region with a strong seasonal contrast in luminosity
46. Effect of menstrual phase on cell proliferative rate of breast cancer
47. Epidermal growth factor receptor and c-erbB-2 expression in normal breast tissue during the menstrual cycle
48. Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture